Relative Bioavailability of BI 1015550 Following Oral Administration Under Fed and Fasted Conditions in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 18 Dec 2017
At a glance
- Drugs BI 1015550 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 14 Dec 2017 Status changed from active, no longer recruiting to completed.
- 28 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 19 Oct 2017 Status changed from not yet recruiting to recruiting.